Vitamin D Supplementation Guidelines

Introduction to Vitamin D Recommendations

• The European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) guidelines suggest that vitamin D intake up to 10,000 IU daily or serum 25(OH)D concentrations up to 240 nmol/L appears safe 1
• The American Academy of Pediatrics recommends measurement of serum 25-hydroxyvitamin D [25(OH)D] levels for diagnosis of vitamin D deficiency, with severe deficiency defined as <5 ng/mL, mild deficiency as 5-15 ng/mL, insufficiency as 16-30 ng/mL, and target level as ≥30 ng/mL 2

Dosage Recommendations

• Preterm infants on parenteral nutrition should receive 200-1000 IU/day (or 80-400 IU/kg/day) of vitamin D 1
• Term infants up to 12 months should receive 400 IU/day (or 40-150 IU/kg/day) of vitamin D 1
• Children and adolescents (1-18 years) should receive 400-600 IU/day of vitamin D 1

• The following tolerable upper intake levels are recommended:

  Age	Tolerable Upper Intake Level
  0-6 months	1000 IU/day
  7-12 months	1500 IU/day
  1-3 years	2500 IU/day
  4-8 years	3000 IU/day
  9-18 years	4000 IU/day [1]

• The American Academy of Pediatrics suggests that treatment of vitamin D deficiency in pediatric patients should follow a structured dosing regimen based on the severity of deficiency, with supplementation doses ranging from 2,000-8,000 IU daily or 50,000 IU weekly depending on serum 25(OH)D levels 2
• The classification and recommended supplementation for vitamin D deficiency are as follows:

2

Monitoring and Supplementation

• For patients on long-term parenteral nutrition, periodic monitoring for vitamin D deficiency is recommended 1
• In patients with persistent 25(OH)D levels <50 nmol/L, additional supplementation should be provided 1
• Oral supplementation should be considered in patients on partial parenteral nutrition and during weaning from parenteral nutrition 1
• The American Academy of Pediatrics recommends measuring serum 25(OH)D levels after 3-6 months of treatment to ensure adequate dosing 3
• The National Kidney Foundation recommends considering calcium supplementation (250-500 mg/day) in patients with low ionized calcium and/or elevated PTH levels 4
• The American Society for Nutrition suggests monitoring ionized calcium, 25-OH-D3, and PTH levels closely during treatment 4

Special Considerations

• Patients with chronic kidney disease (CKD) have a high prevalence (80-90%) of vitamin D insufficiency and may require higher doses of vitamin D 2
• Patients with specific conditions, such as obesity, liver disease, or malabsorption syndromes, may require higher doses of vitamin D (up to 7000 IU/day) and should be monitored closely 5
• Elderly patients (≥71 years) generally require higher doses (800 IU) compared to younger adults (600 IU) due to decreased absorption and increased risk of deficiency 6
• Daily protein intake should be 0.8-1.0 g/kg body weight, with a focus on high-quality protein sources, as recommended by the Proceedings of the Nutrition Society 7
• Target intake for calcium is 950 mg/day, best obtained through diet (dairy products, fortified foods), and supplement only if dietary intake is insufficient, as recommended by the Proceedings of the Nutrition Society 7

Contraindications and Precautions

• Using single large annual doses (500,000 IU) is not recommended due to increased risk of fractures and falls 8
• Failing to account for individual factors like obesity, skin pigmentation, or medication use that may affect vitamin D requirements is not recommended, as it may lead to inadequate supplementation or toxicity 8
• Starting bisphosphonate therapy before correcting vitamin D deficiency is not recommended, as it may increase the risk of hypocalcemia 5
• Daily dosing is preferred for patients with a history of hypercalcemia, primary hyperparathyroidism, granulomatous disorders, or conditions with increased sensitivity to vitamin D, due to the risk of unpredictable fluctuations in calcium levels, and for patients taking medications that affect vitamin D metabolism or calcium levels, such as certain anticonvulsants 8, 2